Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on the Safety and Efficacy of CAR T-cell Therapy for Claudin18.2 Positive Advanced Solid Malignant Tumors

NCT07266311 is registered in ClinicalTrials.gov with Chengdu Ucello Biotechnology Co., Ltd. as lead sponsor.

NCT NCT07266311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07266311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on the Safety and Efficacy of CAR T-cell Therapy for Claudin18.2 Positive Advanced Solid Malignant Tumors
Lead sponsor
Chengdu Ucello Biotechnology Co., Ltd.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
December 15, 2025
Completion date
December 31, 2037
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

claudin18.2 positive advanced solid tumors